scholarly journals Flavor change and food deprivation are not critical for post-oral glucose appetition in mice

2015 ◽  
Vol 140 ◽  
pp. 23-31 ◽  
Author(s):  
Karen Ackroff ◽  
Anthony Sclafani
Keyword(s):  
Food Deprivation ◽  
Oral Glucose ◽  
Flavor Change

Oral Glucose Tolerance as a Test of Liver Function

1953 ◽  
Vol 25 (4) ◽  
pp. 548-552 ◽  
Author(s):  
Thomas J. Rankin ◽  
Robert L. Jenson ◽  
Mahlon Delp
Keyword(s):  
Liver Function ◽  
Glucose Tolerance ◽  
Oral Glucose ◽  
Oral Glucose Tolerance

Asians React Differently to Oral Glucose Test

Ob Gyn News ◽  
2005 ◽  
Vol 40 (8) ◽  
pp. 15
Author(s):  
TIMOTHY F. KIRN
Keyword(s):  
Oral Glucose ◽  
Glucose Test ◽  
Oral Glucose Test

Abstract #873: Association of Patterns in the Oral Glucose Tolerance Test and Different Clinical Features in Patients with Insulinoma

2005 ◽  
Vol 11 ◽  
pp. 28
Author(s):  
Fanny Rodriguez Vallejo ◽  
Juan Manuel Rios Torres ◽  
Francisco J. Gomez-Pérez ◽  
Juan A. Rull Rodrigo ◽  
Bernardo Pérez Enriquez
Keyword(s):  
Glucose Tolerance ◽  
Oral Glucose Tolerance Test ◽  
Clinical Features ◽  
Glucose Tolerance Test ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Oral Glucose Tolerance

ORAL GLUCOSE IN REDUCTION OF JEJUNOSTOMY EFFLUENT

The Lancet ◽  
1971 ◽  
Vol 298 (7224) ◽  
pp. 605
Author(s):  
D Wingate
Keyword(s):  
Oral Glucose

Relation between Plasminogen Activator Inhibitor-1 and Hepatic Enzyme Concentrations in Hyperlipidemic Patients

1994 ◽  
Vol 72 (03) ◽  
pp. 434-437 ◽  
Author(s):  
E Bruckert ◽  
A Ankri ◽  
P Glral ◽  
G Turpin
Keyword(s):  
Blood Pressure ◽  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Tolerance Test ◽  
High Plasma ◽  
Oral Glucose ◽  
Plasminogen Activator Inhibitor 1 ◽  
Glutamyl Transferase ◽  
Activator Inhibitor ◽  
Pai 1

SummaryPlasminogen activator inhibitor type-1 (PAI-1) is a key determinant of the fibrinolytic capacity. Its activity correlates with most of the characteristic features of insulin resistance syndrome, i. e. obesity, high blood pressure and hyperlipidemia.We measured plasma PAI-1 antigen levels in 131 asymptomatic men (aged 44.2 ± 11 years) who had been referred for hyperlipidemia. Those taking medication and those with a secondary hyperlipidemia were excluded.We confirmed the correlation between PAI-1 levels and the following variables: body mass index, blood pressure, triglyceride concentration, and blood glucose and insulin levels before and after an oral glucose tolerance test. We also found a significant and independent correlation between PAI-1 and the concentration of the hepatic enzymes glutamyl transferase, alanine aminotransferase and aspartate aminotransferase.Mild liver abnormalities (presumably steatosis) may thus be one of the factors accounting for high plasma PAI-1 levels in hyperlipidemic patients.

Sign in / Sign up

Export Citation Format

Share Document